Robert C. Horan

FDA investigator

Appears on 13 documents from 1998 to 2018, mostly at sites in New York. Most often cites production record review (21 CFR 211.192).

13
Documents on file
5.8
Observations per 483
1998
First seen
2018
Most recent

What they cite most

From 71 observations

Activity by year

1998: 1, 2006: 1, 2011: 1, 2015: 5, 2016: 1, 2017: 3, 2018: 1

Where

New York 13

Is Robert C. Horan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Luitpold Pharmaceuticals, IncApr 11, 2018 · Shirley, New York
483 Infusion Options, Inc.Jun 1, 2017 · Brooklyn, New York
483 Altaire Pharmaceuticals Inc.Mar 9, 2017 · Aquebogue, New York
483 Spirit PharmaceuticalsJan 25, 2017 · Ronkonkoma, New York
483 Kings Park Slope Inc.Apr 22, 2016 · Brooklyn, New York
483 Altaire Pharmaceuticals, IncDec 15, 2015 · Aquebogue, New York
483 InvaGen Pharmaceuticals, Inc.May 26, 2015 · Hauppauge, New York

About this profile

What does Robert C. Horan inspect?

Robert C. Horan appears on 13 documents on file covering 10 sites, mostly in New York.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Robert C. Horan is dated Apr 11, 2018.